Dave Humphrey
2023 - Ensysce Biosciences
In 2023, Dave Humphrey earned a total compensation of $442K as Chief Financial Officer at Ensysce Biosciences, a 43% decrease compared to previous year.
Compensation breakdown
| Option Awards | $93,800 |
|---|---|
| Salary | $338,250 |
| Other | $9,900 |
| Total | $441,950 |
Humphrey received $338.3K in salary, accounting for 77% of the total pay in 2023.
Humphrey also received $93.8K in option awards and $9.9K in other compensation.
Rankings
In 2023, Dave Humphrey's compensation ranked 2,175th out of 2,978 executives tracked by ExecPay. In other words, Humphrey earned more than 27.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,175 out of 2,978 | 27th |
Division Manufacturing | 1,234 out of 1,637 | 25th |
Major group Chemicals And Allied Products | 739 out of 906 | 18th |
Industry group Drugs | 721 out of 869 | 17th |
Industry Pharmaceutical Preparations | 519 out of 627 | 17th |
Source: SEC filing on October 17, 2024.
Humphrey's colleagues
We found two more compensation records of executives who worked with Dave Humphrey at Ensysce Biosciences in 2023.